Likely active: portfolio news Oct 2026 Verified 4 Nov 2026
M Ventures
Strategic corporate venture fund of Merck KGaA, Darmstadt, Germany, investing since 2009 in biotech (drug development, life science tools) and technology (electronics, frontier tech and sustainability) companies, often taking an active board role.
- Type
- Corporate VC
- Location
- Amsterdam, Netherlands
- Backs
- Biotech and pharma
- Sectors
- Biotech, Healthtech and life sciences, AI, Deep tech, Climate and cleantech
- Fund size / AUM
- $26.9M gross private fund assets (Form ADV; private funds: 2, of which venture capital: 2)
- Portfolio mix
- Biotech and pharma 92%; B2B software 4%; Medtech and digital health 4% (n=29)
- Website
- www.m-ventures.com
Contacts on file
For M Ventures, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked); LinkedIn page.
Get Europe Complete, $99 Free sample
One-time payment. No subscription. No account.
Notable investments
NouscomLabGeniusMemryXMosa MeatTranslate Bio
Sources
- www.m-ventures.com/
- www.m-ventures.com/portfolio
- www.m-ventures.com/team
- www.m-ventures.com/contact
- adviserinfo.sec.gov/firm/summary/296621
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 15 lists
Startup investors in Amsterdam (24)Corporate venture capital firms in Europe (46)Startup investors in the Netherlands (69)Corporate venture capital firms (84)Biotech investors in Europe (89)AI investors in Europe (230)Climate tech investors in Europe (250)Healthtech investors in Europe (291)Deep tech investors in Europe (299)Biotech investors (484)Climate tech investors (660)Startup investors in Europe (725)Deep tech investors (763)Healthtech investors (1,207)AI investors (1,576)